Logistic and multilevel regression analyses showed that tree survival, growth and thinning response (change of tree growth due to a thinning treatment) were functions of tree species, size, age, removed and remaining competition, as well as time since the treatment.
Individualized treatment rules are functions of model parameters (usually treatment contrasts reflecting differences in treatment effects) which must be estimated from the assumed statistical model and training data.
Correlation between patient characteristics and adherence to outcome-indicators (treatment sessions, functioning of patient, accomplished goals) was calculated using univariate logistic regression.
Here, we set out to determine whether transcriptional repression by engineered ZFP technology represents a novel therapeutic gene-silencing paradigm for the treatment of gain-of-function mutations.
An approach that has attracted much interest as an emerging strategy for the treatment of loss-of-function genetic diseases, including LSDs, is PCT with small molecule compounds.
This revealed that the AZO nanorod array thin film with hydrogen treatment possessed the functions of TCO thin film and photoelectrode simultaneously.
Aluminum-doped zinc oxide (AZO) nanorod array thin film with hydrogen treatment possesses the functions of transparent conducting oxide thin film and 1-D nanostructured semiconductor simultaneously.
We found evidence for separate, but complementary, effects of SOD and insulin treatment on the functions of glucose-stressed EPCs.
Second, we modeled recolonization (the colonization of new households after the initial treatment) as a function of treatment phase factors.
As it was not possible to introduce CifYp into cells using either the infection or BioPORTER treatments, the function of this protein was analysed directly by expressing cifYp in HeLa cells.
Unfortunately, the basic data collected did not allow us to stratify the treatments undertaken as a function of treatment stage (on-treatment or post-treatment).
